A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development.

Commun Biol · 2025 · PMC12081850 · PMID 40374778

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

7G ), however, only CD33-TCB treatment showed a trend towards reducing total myeloid cell counts (Fig. 7H ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.